XHKG
1418
Market cap53mUSD
Dec 04, Last price
0.24HKD
1D
-4.00%
1Q
0.00%
Jan 2017
-61.90%
IPO
-77.14%
Name
Sinomax Group Ltd
Chart & Performance
P/E
3.04
P/S
0.10
EPS
0.08
Div Yield, %
9.58%
Shrs. gr., 5y
—
Rev. gr., 5y
6.42%
Revenues
4.09b
+13.36%
Net income
138m
+120.58%
CFO
250m
-40.54%
Dividend
Jun 16, 20250.013 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sinomax Group Limited, an investment holding company, manufactures, and sells health and household products, and polyurethane foam. The company offers viscoelastic pillows, mattress toppers, and mattresses under the SINOMAX, Octaspring, Zeopedic, Zeosleep, PureLUX, Dream Serenity, ComforZen, Cradlez, Customizer, Design, Spa Supreme, and Tung Ah brands. It sells its products through self-operated stand-alone retail shops and concession counters in department store, as well as internet. The company also engages in the retail and wholesale of health and household products; and provision of treasury management services. It has operations in the People's Republic of China, Hong Kong, and Macau; the United States, Canada, and other North American countries; and Europe and internationally. The company was founded in 2000 and is headquartered in Kowloon Bay, Hong Kong. Sinomax Group Limited is a subsidiary of Sinomax Enterprises Limited.
IPO date
Jul 10, 2014
Employees
2,742
Domiciled in
HK
Incorporated in
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||